
Center for Pathophysiology, Infectiology and Immunology (Institute of Immunology)
Position: Professor
ORCID: 0000-0001-8192-8481
T +43 1 40160 33293
wilfried.ellmeier@meduniwien.ac.at
Keywords
Antigens, Differentiation, T-Lymphocyte; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Gene Regulatory Networks; Inflammation; T Cells; T-Lymphocyte Subsets
Research interests
Our long-term research interest is to characterize molecular mechanisms that regulate the development and function of T lymphocytes. With our studies we aim to provide important and medical relevant insight into the regulation of T cell-mediated immunity. In ongoing studies we address the following research topics:
• Histone deacetylase function in T cell-mediated immunity
• Transcriptional control of T cell development and function
• Regulation of T cell lineage identity and integrity
For more information please visit: www.meduniwien.ac.at/immunobiology
Techniques, methods & infrastructure
The experimental strategies to address our research interests include immunological tools, biochemical and molecular approaches, next generation sequencing, retroviral-mediated gene transduction into hematopoietic stem cells, and mouse molecular genetics tools.
Grants
- MAZR isoform-specific functions in T cells and beyond (2021)
Source of Funding: FWF (Austrian Science Fund), Stand-alone project
Principal Investigator - European Network Linking Informatics and Genomics of Helper T cells in Tissues (2020)
Source of Funding: EU, Innovative Training Network (ITN)
Principal Investigator - HDACs as regulators of T cell-mediated immunity in health and disease (2019)
Source of Funding: FWF (Austrian Science Fund), Special Research Program (SFB)
Coordinator of the collaborative project
Selected publications
- Sakaguchi, S. et al., 2010. The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes. Nature Immunology, 11(5), pp.442–448. Available at: http://dx.doi.org/10.1038/ni.1860.
- Boucheron, N. et al., 2014. CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2. Nature Immunology, 15(5), pp.439–448. Available at: http://dx.doi.org/10.1038/ni.2864.
- Göschl, L. et al., 2018. A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis. Journal of Autoimmunity, 86, pp.51–61. Available at: http://dx.doi.org/10.1016/j.jaut.2017.09.008.
- Ellmeier, W. & Seiser, C., 2018. Histone deacetylase function in CD4+ T cells. Nature Reviews Immunology, 18(10), pp.617–634. Available at: http://dx.doi.org/10.1038/s41577-018-0037-z.
- Hamminger, P. et al., 2021. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases. Journal of Autoimmunity, 119, p.102610. Available at: http://dx.doi.org/10.1016/j.jaut.2021.102610.